An investigational, novel combination therapy, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized relapse prevention ...
But it doesn't have to be this way. Take back control of your brain and break free from dopamine addiction. Dr. Andrew Huberman, professor of neurobiology at Stanford School of Medicine ...
1Department of Medicine, Columbia Center for Human Development, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York. 2Herbert Irving Comprehensive ...
If you’re looking to try CBD but don’t like the taste from CBD gummies or oils, CBD capsules could be a solution for you. Take a look at our picks to get your search started. Cannabidiol (CBD ...
Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of ...